Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LTFNBTC

(LTFNBTC)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/02/20248:56AMGlobeNewswire Inc.NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With HoloscanNASDAQ:NVDANVIDIA Corporation
06/02/20248:52AMGlobeNewswire Inc.NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autonomous MachinesNASDAQ:NVDANVIDIA Corporation
06/02/20248:44AMGlobeNewswire Inc.Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and OmniverseNASDAQ:NVDANVIDIA Corporation
06/02/20248:42AMPR Newswire (US)Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
06/02/20248:41AMGlobeNewswire Inc.NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCsNASDAQ:NVDANVIDIA Corporation
06/02/20248:35AMGlobeNewswire Inc.Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial RevolutionNASDAQ:NVDANVIDIA Corporation
06/02/20248:32AMGlobeNewswire Inc.NVIDIA Supercharges Ethernet Networking for Generative AINASDAQ:NVDANVIDIA Corporation
06/02/20248:30AMBusiness WireDenodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
06/02/20248:30AMBusiness WireDenodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
06/02/20248:30AMPR Newswire (US)Vention to democratize industrial automation using NVIDIA AI technologies
06/02/20248:30AMPR Newswire (US)Crimson Cup Coffee & Tea Publishes 2024 Guide on How to Start a Coffee Shop in California
06/02/20248:30AMPR Newswire (Canada)Vention to democratize industrial automation using NVIDIA AI technologies
06/02/20248:30AMPR Newswire (Canada)Message de la gouverneure générale et commandante en chef du Canada à l'occasion de la Journée des Forces armées canadiennes
06/02/20248:30AMPR Newswire (Canada)Message from the Governor General and Commander-in-Chief of Canada on Canadian Armed Forces Day
06/02/20248:13AMGlobeNewswire Inc.NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI DevelopersNASDAQ:NVDANVIDIA Corporation
06/02/20248:11AMGlobeNewswire Inc.NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI AvatarsNASDAQ:NVDANVIDIA Corporation
06/02/20248:05AMBusiness WireIMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placeboNASDAQ:AZNAstraZeneca PLC
06/02/20248:00AMBusiness WireENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapyNASDAQ:AZNAstraZeneca PLC
06/02/20248:00AMGlobeNewswire Inc.CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
06/02/20248:00AMGlobeNewswire Inc.Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)NASDAQ:NTLAIntellia Therapeutics Inc
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNYSE:RCUSArcus Biosciences Inc
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
06/02/20248:00AMGlobeNewswire Inc.William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
06/02/20248:00AMBusiness WireMassive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
06/02/20248:00AMBusiness WireENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNYSE:RCUSArcus Biosciences Inc
06/02/20248:00AMPR Newswire (US)OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
06/02/20247:20AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024/
06/02/20247:20AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024/

Your Recent History

Delayed Upgrade Clock